5 Results for "

human CB2R

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "human CB2R" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-119104
CAS No.: 881413-29-2
Purity:  99.58%
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pKi values of 7.93 and 9.06 for human CB1R and CB2R, respectively. AZD1940 shows a robust analgesia action .
loading...
    loading...
Cat. No.: HY-152581
Purity:  98.08%
Target:  

Cannabinoid Receptor

Research Areas:  

Inflammation/Immunology

CB2R antagonist 3 is a selective antagonist of cannabinoid type 2 receptor (CB2R). CB2R antagonist 3 has high affinity for human CB2R and specific selectivity for CB1R. CB2R antagonist 3 can be combined with CB65 (HY-110047), the activator of CB2R. CB2R antagonist 3 effectively up-regulates the expression of anti-inflammatory cytokines and down-regulates the expression of pro-inflammatory cytokines .
loading...
    loading...
Cat. No.: HY-152576
CAS No.: 1817633-49-0
Target:  

Cannabinoid Receptor

Research Areas:  

Inflammation/Immunology

CB2R agonist 1 is a selective ligand of cannabinoid receptor subtype 2 (CB2R) with an EC50 value of 0.56 µM. CB2R agonist 1 has high affinity and excellent selectivity for human CB2R and CB1R respectively. CB2R agonist 1 regulates the production of pro-inflammatory cytokines and anti-inflammatory cytokines and play an immunomodulatory role .
loading...
    loading...
Cat. No.: HY-145604
CAS No.: 1433361-02-4
Purity:  98.37%
Synonyms: RG7774
Vicasinabin (RG7774) is an orally active, selective, and full CB2R agonist, with EC50 values of 2.81 nM and 2.60 nM for human CB2R and mouse CB2R, respectively. Vicasinabin inhibits inflammation, reduces leukocyte adhesion and decreases vascular permeability by selectively activating CB2R. Vicasinabin can be used in the researches for diabetic retinopathy, uveitis and laser-induced choroidal neovascularization .
loading...
    loading...
Cat. No.: HY-187205
CAS No.: 3105939-80-5
Research Areas:  

Neurological Disease

Glutaminyl cyclase/CB2R modulator-1 (Compound 18) acts as an inhibitor of glutaminyl cyclase (QC) (IC50 = 0.65 μM) and an agonist of cannabinoid receptor type 2 (CB2R) (EC50 = 0.32 μM). Glutaminyl cyclase/CB2R modulator-1 can be used for the research of Alzheimer's disease .
loading...
    loading...